» Articles » PMID: 17190852

A Metabolomic Comparison of Urinary Changes in Type 2 Diabetes in Mouse, Rat, and Human

Overview
Date 2006 Dec 28
PMID 17190852
Citations 166
Authors
Affiliations
Soon will be listed here.
Abstract

Type 2 diabetes mellitus is the result of a combination of impaired insulin secretion with reduced insulin sensitivity of target tissues. There are an estimated 150 million affected individuals worldwide, of whom a large proportion remains undiagnosed because of a lack of specific symptoms early in this disorder and inadequate diagnostics. In this study, NMR-based metabolomic analysis in conjunction with multivariate statistics was applied to examine the urinary metabolic changes in two rodent models of type 2 diabetes mellitus as well as unmedicated human sufferers. The db/db mouse and obese Zucker (fa/fa) rat have autosomal recessive defects in the leptin receptor gene, causing type 2 diabetes. 1H-NMR spectra of urine were used in conjunction with uni- and multivariate statistics to identify disease-related metabolic changes in these two animal models and human sufferers. This study demonstrates metabolic similarities between the three species examined, including metabolic responses associated with general systemic stress, changes in the TCA cycle, and perturbations in nucleotide metabolism and in methylamine metabolism. All three species demonstrated profound changes in nucleotide metabolism, including that of N-methylnicotinamide and N-methyl-2-pyridone-5-carboxamide, which may provide unique biomarkers for following type 2 diabetes mellitus progression.

Citing Articles

Investigation of pH-dependent H NMR urine metabolite profiles for diagnosis of obesity-related disordering.

Wu D, Fajiculay E, Hsu C, Hu C, Lee L, Tzou D Int J Obes (Lond). 2024; .

PMID: 39658677 DOI: 10.1038/s41366-024-01695-0.


Exploring NNMT: from metabolic pathways to therapeutic targets.

Park J, Shin E, Kim T, Yang J, Ki S, Kang K Arch Pharm Res. 2024; 47(12):893-913.

PMID: 39604638 DOI: 10.1007/s12272-024-01519-9.


The effects of chicory inulin-type fructans supplementation on weight management outcomes: systematic review, meta-analysis, and meta-regression of randomized controlled trials.

Reimer R, Theis S, Zanzer Y Am J Clin Nutr. 2024; 120(5):1245-1258.

PMID: 39313030 PMC: 11600113. DOI: 10.1016/j.ajcnut.2024.09.019.


Nicotinamide N-methyltransferase (NNMT): a novel therapeutic target for metabolic syndrome.

Sun W, Zhu X, Li J, Mei Y, Li W, Li J Front Pharmacol. 2024; 15:1410479.

PMID: 38919254 PMC: 11196770. DOI: 10.3389/fphar.2024.1410479.


Pilot-Study to Explore Metabolic Signature of Type 2 Diabetes: A Pipeline of Tree-Based Machine Learning and Bioinformatics Techniques for Biomarkers Discovery.

Yagin F, Al-Hashem F, Ahmad I, Ahmad F, Alkhateeb A Nutrients. 2024; 16(10).

PMID: 38794775 PMC: 11124278. DOI: 10.3390/nu16101537.